Latest papers

Pigmented lesions of the vulva.

[Potentially malignant disorders of the oral mucosa: terminology and classification].

[Upper aerodigestive tract erythroplakia].

Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.

A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.

Early survival of a compromised fasciocutaneous flap without pedicle revision: monitoring with photoplethysmography.

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.

Why did so many women develop cancer? Part 2.

Why won't defenders of the Cartwright Inquiry provide evidence to justify their use of the term 'conventional treatment' for carcinoma in situ?

Permanent chemotherapy-induced alopecia: case report and review of the literature.

Induction of cell growth arrest and apoptotic cell death in human breast cancer MCF-7 cells by the COX-1 inhibitor FR122047.

PIK3CA mutations in in situ and invasive breast carcinomas.

Urothelial carcinoma in situ of the urinary bladder with columnar cell pattern.

Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.

Pathological stage review is indicated in primary pT1 bladder cancer.

Use of serum progesterone concentration for timing breast MRI examinations and avoiding false-negative findings.

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.

Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.

Mohs surgery for melanoma in situ: how we do it.

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.